Virbac Balance Sheet Health
Financial Health criteria checks 6/6
Virbac has a total shareholder equity of €994.2M and total debt of €370.0M, which brings its debt-to-equity ratio to 37.2%. Its total assets and total liabilities are €1.8B and €802.0M respectively. Virbac's EBIT is €227.3M making its interest coverage ratio 87.6. It has cash and short-term investments of €158.6M.
Key information
37.2%
Debt to equity ratio
€369.96m
Debt
Interest coverage ratio | 87.6x |
Cash | €158.64m |
Equity | €994.24m |
Total liabilities | €801.99m |
Total assets | €1.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0NM7's short term assets (€877.3M) exceed its short term liabilities (€530.6M).
Long Term Liabilities: 0NM7's short term assets (€877.3M) exceed its long term liabilities (€271.4M).
Debt to Equity History and Analysis
Debt Level: 0NM7's net debt to equity ratio (21.3%) is considered satisfactory.
Reducing Debt: 0NM7's debt to equity ratio has reduced from 94.1% to 37.2% over the past 5 years.
Debt Coverage: 0NM7's debt is well covered by operating cash flow (37.5%).
Interest Coverage: 0NM7's interest payments on its debt are well covered by EBIT (87.6x coverage).